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INTRODUCTION
Gastroesophageal reflux disease (GERD) is a major clinical
problem in Western countries. Several recent endoscope-based
studies have suggested that the overall prevalence of reflux
esophagitis (RE) in Western countries was around 10-20%
(1). In contrast, GERD has traditionally been considered to
be less common in Asia (2). However, more recent studies
suggest that the prevalence of GERD in Asia is increasing.
In Japan, the overall prevalence of RE among the adult pop-
ulation is roughly 16% (3). In Taiwan, the prevalence of RE
in patients evaluated for upper gastrointestinal tract symp-
toms is 15% (4). These findings are similar to those report-
ed in the West.
RE has been considered fairly rare among ethnic Koreans.
However, recent studies have shown that the incidence is in-
creasing in the Korean population. The prevalence of RE in
subjects undergoing a routine check-up was reported to 2.36%
in 1993 (2), and 3.4% in 1997 (5). In 1999, the prevalence
of RE was found to be 5.3% in subjects with gastrointestinal
symptoms (6). The incidence is expected to increase not only
due to developments in endoscopic examination and increas-
ing awareness of the condition, but also because of changes in
preference to a more Westernized diet, as well as changes in
lifestyle. However, despite awareness of the increasing preva-
lence of RE, few studies have been performed to investigate
the risk factors of RE in Korea.
This study was performed to estimate the prevalence of RE
in healthy Korean subjects and to elucidate the differences in
clinical characteristics between subjects with RE and those
without.
MATERIALS AND METHODS
Subject population
We retrospectively examined the medical records of healthy
subjects who were examined by endoscopy in a routine check-
up program of a single university hospital from October 2004
to September 2005. A total of 6,082 subjects were enrolled
in the study. Because this was a retrospective study, reflux sy-
mptoms such as heartburn, dyspepsia, epigastric pain, and
belching were not investigated. Evaluation about smoking
and alcohol drinking was performed. The presence of Heli-
cobacter pylori (H. pylori) infection was diagnosed by rapid ure-
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The Prevalence and Clinical Characteristics of Reflux Esophagitis in
Koreans and Its Possible Relation to Metabolic Syndrome
The prevalence of reflux esophagitis is increasing in Korea. To estimate the preva-
lence and clinical characteristics of reflux esophagitis in healthy subjects, we retro-
spectively examined the medical records of healthy subjects undergoing a routine
check-up from October 2004 to September 2005. A total of 6,082 (3,590 men, mean
age 44±10 yr) subjects were enrolled in this study. The prevalence of reflux esophagi-
tis in healthy subjects was 10.5%. According to the univariate analysis, male sex
(odds ratio [OR] 3.49, 95% confidence interval [CI] 2.84-4.30), smoking history (OR
1.91, 95% CI 1.60-2.28), body mass index (BMI) >30 kg/m
2 (OR 2.13, 95% CI 1.37-
3.33), total cholesterol >250 mg/dL (OR 1.50, 95% CI 1.05-2.14), low-density lipopro-
tein (LDL) cholesterol ≥160 mg/dL (OR 1.52, 95% CI 1.08-2.14), triglyceride ≥150
mg/dL (OR 1.92, 95% CI 1.61-2.30), high blood pressure (BP) (OR 1.46, 95% CI
1.20-1.76), and fasting glucose ≥110 mg/dL (OR 1.45, 95% CI 1.13-1.86) were
significantly associated with reflux esophagitis (all p<0.05). However, age, alcohol
drinking and Helicobacter pylori infection were not associated with reflux esophagi-
tis. In conclusiosn, significant relationships of reflux esophagitis with obesity, low
high-density lipoprotein (HDL) cholesterol, high triglyceride, high BP, and elevated
fasting glucose suggested that reflux esophagitis might represent the disease spec-
trum of the metabolic syndrome.
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Accepted : 26 June 2008ase test (Asan Helicobacter test, Asan pharm.co., LTD., Seoul,
Korea) or histologic findings from the biopsy specimens. The
esophagogastroduodenoscopy (EGD) was a component of a
complete medical examination that includes routine studies
of blood, urine, stool, and an ultrasound of the abdomen. The
body mass index (BMI) was calculated using the following
formula: BMI=weight (kg)/height
2 (m
2). Data for blood pres-
sure (BP), total cholesterol, low-density lipoprotein (LDL)
cholesterol, high-density lipoprotein (HDL) cholesterol, tri-
glyceride, and fasting glucose were also collected. High BP
was defined as ≥130/85 mmHg or documented use of anti-
hypertensive therapy according to National Cholesterol Edu-
cation Program (NCEP) criteria (7).
Metabolic syndrome was defined based on the World Health
Organization (WHO) criteria and NCEP criteria. Under the
WHO criteria, the diagnosis of metabolic syndrome can be
made in subjects with type 2 DM, impaired glucose tolerance,
or insulin resistance, and also requires at least two of the fol-
lowing four components: 1) hypertension, either treated with
medication or ≥160/90 mmHg untreated; 2) dyslipidemia
with elevated plasma triglyceride (≥150 mg/dL) and/or low
HDL (<35 mg/dL in men, <39 mg/dL in women); 3) obe-
sity with BMI ≥30 kg/m
2or central adiposity (waist-hip ratio
>0.90 in men or >0.85 in women); and 4) microalbuminuria
(urinary average excretion rate ≥20 μ g/min or albumin-cre-
atinine ratio ≥20 mg/g). The NCEP criteria for metabolic
syndrome require at least three of the following: waist circum-
ference >40 inch in men or >35 inch in women, plasma tri-
glyceride ≥150 mg/dL, HDL cholesterol <40 mg/dL in men
or <50 mg/dL in women, blood pressure ≥130/85 mmHg,
and fasting plasma glucose ≥110 mg/dL (7).
Endoscopic findings
The severities of RE were defined by the Los Angeles clas-
sification (1). The criteria for the diagnosis of esophagitis were:
grade A, one or more mucosal breaks confined to the mucosal
folds, each no longer than 5 mm; grade B, at least one mucosal
break more than 5 mm long confined to the mucosal folds;
grade C, at least one mucosal break continuing between the
tops of two or more mucosal folds but not circumferential;
grade D, circumferential mucosal break. Minimal change
esophagitis was excluded because of low interobserver agree-
ment (8).
Statistical analysis
The differences of mean value in age, BMI, total cholesterol,
LDL cholesterol, HDL cholesterol, triglyceride, and fasting
glucose were evaluated using Student’s t test. Categorical vari-
ables such as sex, smoking, alcohol drinking and H. pylori in-
fection were evaluated using Pearson chi-square test. The risk
of reflux esophagitis was calculated by logistic regression anal-
ysis with regards to several variables, including age, sex, smok-
ing, alcohol drinking and H. pylori infection, BMI, high BP,
total cholesterol, LDL cholesterol, HDL cholesterol, triglyc-
eride, and fasting glucose. A p value below 0.05 was consid-
ered to be statistically significant. The software package used
for analysis was SPSS version 13.0 (SPSS Inc., Chicago, IL,
U.S.A.).
RESULTS
Prevalence and age distribution
Among a total of 6,082 subjects (3,590 male and 2,492
female, mean age 44±10 yr, 17-83 yr) (Fig. 1), 639 subjects
were found to have RE, and the overall prevalence was 10.5%.
The prevalence of RE in male was 14.6% (523 of 3,590), the
prevalence of RE in female was only 4.7% (116 of 2,376) (p<
0.01). When the age group was stratified by 17-29, 30-39,
40-49, 50-59, 60-69, and 70-83 yr, the prevalence of RE ra-
nged from 10.4 % to 15.8% in each age group among male.
In contrast, the prevalence of RE ranged 3.7% 9.4% in each
age group among female. The prevalence of RE was similar
in each age group between both sexes (Fig. 2).
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Fig. 1. Age distribution of the subjects.
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Fig. 2. Prevalence of reflux esophagitis in each age group. The pr-
evalence of reflux esophagitis was similar in each age group betwe-
en both sexes.
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Male (n=3,590)
Female (n=2,492)Endoscopic findings of subjects with RE
Most of the subjects showed mild grade RE with 519 (81
%) of the subjects presenting with grade A, followed by 112
(17.5%) with grade B and 8 (1.3%) with grade C. No sub-
jects presented with grade D (Table 1).
Clinical features of subjects with and without RE
The difference in mean age between subjects with and wi-
thout RE was not statistically significant (43.9±9.6 yr vs.
43.2±9.7 yr, p=0.5). Male sex was predominant in subjects
with RE (81.8%) than those without (56.4%) (p<0.01). Smok-
ing history was significantly higher in subjects with RE (34.6
%) than those without (21.6%) (p<0.01). However, alcohol
drinking (91.7% vs. 89.9%), and H. pylori infection (2.7% vs.
4.1%) were not significantly different between the two groups.
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LA classification
Male Female Total
n (%) n (%) n (%)
A 410 (64.2) 109 (17.1) 519 (81.2)
B 106 (16.6) 6 (0.9) 112 (17.5)
C 7 (1.1) 1 (0.2) 8 (1.3)
D 0 (0.0) 0 (0.0) 0 (0.0)
Total 523 (81.8) 116 (8.2) 639 (100.0)
LA, los argeles.
Table 1. LA classification of subjects with reflux esophagitis ac-
cording to sex
Variable
Odds ratio Univariate
(95% CI) analysis (p)
Age (yr)
Age ≤65 (n=5,904) 1.05 (0.64-1.71) 0.86
Age >65 (n=178)
Sex
Female (n=2,492) 3.49 (2.84-4.30) <0.01
Male (n=3,590)
Smoking history
No 1.91 (1.60-2.28) <0.01
Yes
Alcohol drinking
No 0.81 (0.60-1.09) 0.16
Yes
H. pylori infection
No 1.59 (0.85-2.98) 0.15
Yes
BMI (kg/m
2)
BMI ≤30 (n=5,341) 2.13 (1.37-3.33) <0.01
BMI >30 (n=102)
Total cholesterol (mg/dL)
≤250 (n=5,824) 1.50 (1.05-2.14) 0.03
>250 (n=258)
LDL cholesterol (mg/dL)
<160 (n=5,791) 1.52 (1.08-2.14) 0.01
≥160 (n=291)
HDL Cholesterol (mg/dL)
Male
<40 (n=434) 1.04 (0.81-1.34) 0.74
≥40 (n=2,557)
Female
<50 (n=85) 0.95 (0.62-1.45) 0.81
≥50 (n=1,714)
Triglyceride (mg/dL)
≤150 (n=4,732) 1.91 (1.61-2.30) <0.01
>150 (n=1,350)
High blood pressure
No 1.46 (1.20-1.76) <0.01
Yes
Fasting glucose (mg/dL)
<110 (n=5,492) 1.45 (1.13-1.86) <0.01
≥110 (n=590)
BMI, body mass index; CI, confidence interval; high blood pressure,
≥130/85 mmHg or documented use of antihypertensive therapy.
LDL, low-density lipoprotein; HDL, high-density lipoprotein.
Table 3. Logistic regression analysis of covariables for reflux eso-
phagitis
Subjects Subjects  
Variable
with reflux without reflux
p value
esophagitis esophagitis
(n=639) (n=5,443)
Age (yr) 43.9±9.6 43.2±9.9 0.5
Sex
Male (%) 523 (81.8) 3,067 (56.4) <0.01
Female (%) 116 (18.2) 2,376 (43.6)
Smoking history
Yes (%) 221 (34.6) 1,180 (21.7) <0.01
No (%) 418 (65.4) 4,263 (78.3)
Alcohol drinking
Yes (%) 586 (91.7) 4,895 (89.9) 0.16
No (%) 53 (8.3) 548 (10.1)
Helicobacter pylori infection*
Positive (%) 11 (2.7) 106 (4.1) 0.15
Negative (%) 404 (97.3) 2,451 (95.9)
BMI (kg/m
2) 24.7±2.8 23.6±2.9 <0.01
Total cholesterol (mg/dL) 191.2±33.6 188.3±32.6 0.04
LDL cholesterol (mg/dL) 112.2±28.1 109.7±27.5 0.03
HDL cholesterol (mg/dL) 50.7±12.1 53.5±12.7 <0.01
Triglyceride (mg/dL) 134.6±80.1 113.5±83.2 <0.01
High blood pressure
�
Yes (%) 163 (25.6%) 1,035 (19.1%) <0.01
No (%) 473 (74.4%) 4,375 (80.9%)
Fasting glucose (mg/dL) 98.1±16.7 96.3±18.8 0.02
*Data on Helicobacter pylori infection were unavailable for 224 (35.1%)
subjects with reflux esophagitis and for 2,886 (53.0%) subjects without
reflux esophagitis; 
� Data on high blood pressure were unavailable for 3
(0.5%) subjects with reflux esophagitis and for 33 (0.6%) subjects with-
out reflux esophagitis.
BMI, body mass index; high blood pressure, ≥130/85 mmHg or doc-
umented use of antihypertensive therapy.
LDL, low-density lipoprotein; HDL, high-density lipoprotein.
Table 2. A comparison of clinical characteristics between sub-
jects with reflux esophagitis and those withoutAnd BMI was also found to be significantly higher in sub-
jects with RE than in those without (24.7±2.8 kg/m
2 vs.
23.6±2.9 kg/m
2, p<0.01), as were total cholesterol (191.2
±33.6 mg/dL vs. 188.3±32.6 mg/dL, p=0.04), LDL choles-
terol (112.2±28.1 mg/dL vs. 109.7±27.5 mg/dL, p=0.03),
triglyceride (134.6±80.1 mg/dL vs. 113.5±83.2 mg/dL,
p<0.01), high BP (25.6% vs. 19.1%, p<0.01), and fasting
glucose (98.1±16.7 mg/dL vs. 96.3±18.8 mg/dL, p=0.02).
HDL cholesterol (50.7±12.1 mg/dL vs. 53.5±12.7 mg/dL,
p<0.01) was significantly lower in subjects with RE than in
those without (Table 2). 
Risk factors of RE
According to univariate analysis, male sex (odds ratio [OR]
3.49, 95% confidence interval [CI] 2.84-4.30), smoking his-
tory (OR 1.91, 95% CI 1.60-2.28), BMI >30 kg/m
2 (OR
2.13, 95% CI 1.37-3.33), total cholesterol >250 mg/dL (OR
1.50, 95% CI 1.05-2.14), LDL cholesterol ≥160 mg/dL
(OR 1.52, 95% CI 1.08-2.14), triglyceride ≥150 mg/dL
(OR 1.92, 95% CI 1.61-2.30), high BP (OR 1.46, 95% CI
1.20-1.76), and fasting glucose ≥110 mg/dL (OR 1.45,
95% CI 1.13-1.86) were significant risk factors of RE (all
p<0.05). However, old age (age >65 yr, OR 1.05, 95% CI
0.64-0.71), alcohol drinking (OR 0.81, 95% CI 0.60-1.09)
and H. pylori infection (OR 1.59, 95% CI 0.85-2.98) were
not shown to be significant risk factors of RE. Low HDL
cholesterol (male <40 mg/dL, female <50 mg/dL) was not a
significant risk factor in males (OR 1.04, 95% CI 0.81-1.34)
and females (OR 0.95, 95% CI 0.62-1.45) (Table 3). 
DISCUSSION
GERD is one of the most prevalent digestive diseases expe-
rienced in Western countries. In the United States, the preva-
lence is about 1,900,000 cases/yr and the annual cost of
diagnosis and treatment is 93,000,000,000 dollars (9). The
prevalence of GERD-related complications, including RE,
Barrett’s esophagus, and esophageal adenocarcinoma has been
steadily increasing in the United States and Western Europe.
As the reasons for the increase in GERD and its complica-
tions, changes in diet, smoking, and alcohol intake as well as
the declining prevalence of H. pylori infection have been pro-
posed (10). In our results, smoking was an important risk fac-
tor, however, alcohol drinking and H. pylori infection had no
relationships with GERD. Studies have also hypothesized that
the increasing trend of obesity in Western countries has par-
alleled the increase in esophageal adenocarcinoma and may
be an important factor in this change (11).
In Korea, it is generally accepted that the nationwide preva-
lence of RE is lower than that in Western countries. However,
recent studies have shown that the numbers of patients with
RE have shown an increasing trend (2, 5, 6). In this study,
endoscopic examination indicated that the overall prevalence
of RE was 10.5% close to that of Western countries (10-20%)
(1). The possible causes for the increasing prevalence in RE
observed in the Korean population are of great interest. Patient
selection, increased referrals for endoscopy, and marked impro-
vement in diagnostic techniques may partially explain this
trend. Furthermore, obesity shows an increasing trend as a
cause of RE in Korea. A recently reported study indicated
that the prevalence of overweight (25≤BMI≤30 kg/m
2)
and obesity (BMI >30 kg/m
2) was 23.4% and 1.7% in males
and 24.9% and 3.2% in females in 1998 (11). However, in
2001, the prevalence of overweight or obesity in Korean adults
was 30.6% (32.4% in males and 29.4% in females) (12). In
our study, the prevalence of overweight and obesity were 36.9
%, 2.1% in males and 21.3%, 2.1% in females, respectively,
and BMI was found to be significantly higher in subjects with
RE than that in those without (24.7±2.8 kg/m
2 vs. 23.6±
2.9 kg/m
2, p<0.01). BMI >30 kg/m
2 was found to be a signifi-
cant risk factor of RE by univariate analysis (OR 2.13, 95%
CI 1.37-3.33).
Obesity may affect esophageal reflux through mechanical
factors and humoral factors. Such mechanical factors include
increased intra-abdominal pressures, impaired gastric emp-
tying, decreased lower esophageal sphincter pressure, and in-
creased frequency of transient lower esophageal sphincter relax-
ation, thus leading to increased esophageal acid exposure (10).
The humoral mechanisms are not well known. It has been
hypothesized that estrogen also influences reflux in obese pa-
tients. Two studies conducted by the same group of investi-
gators from Sweden observed that the association between obe-
sity and GERD might be mediated by estrogen (13, 14). The
first study reported a statistically significant association be-
tween obesity and esophagitis in women, which was poten-
tiated by the use of estrogen in postmenopausal women (13).
The second study found that obese women were at increased
risk of experiencing symptoms of GERD compared with obese
men, and the risk was highest in premenopausal women and
postmenopausal women receiving estrogen therapy (14).
Few reports have assessed the association between dyslipi-
demia and GERD. Total cholesterol was found to be higher
in subjects with RE with borderline significance than in the
general population, but HDL cholesterol levels did not dif-
fer (15). However, in this study, we found that dyslipidemia
can be a possible causative factor of RE. Using univariate logis-
tic regression analysis, it was found that total cholesterol >250
mg/dL, LDL cholesterol ≥160 mg/dL, and triglyceride ≥150
mg/dL were associated with the occurrence of RE. HDL choles-
terol was significantly lower in subjects with RE than in those
without the condition, but low HDL cholesterol (male <40
mg/dL, female <50 mg/dL) was not found to be a significant
risk factor. This could potentially be explained by relatively
low proportion of the subject’s population with low HDL ch-
olesterol.
It is known that the prevalence of RE in adults increases
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between subjects with and without esophagitis was not sta-
tistically significant. This is may be due to the enrollment
of a relatively young subject population (age ≤65: n=5,904
vs. age >65: n=178). When we divided the age by subgroup,
there were no significant differences within the both sexes.
There is a male preponderance in RE, which ranges from 2:1
to 3:1 in comparison to females (18). The preponderance of
males with RE in the present study was more evident (M:F=
4.5:1). According to univariate analysis, male sex was signif-
icant risk factor of RE (OR 3.49, 95% CI 2.84-4.30).
Hypertension has been reported as frequently present in
patient with RE (15). The present study showed that high
BP was risk factor of RE as well (OR 1.46, 95% 1.20-1.76),
but we did not investigate drug therapy in the subjects who
underwent endoscopic examination. Calcium antagonists are
used to treat hypertension, but these drugs also decrease the
lower esophageal sphincter pressure and inhibit muscle con-
traction in the esophagus itself (19). In Korea, calcium antag-
onists are widely used to treat hypertension, so it is possible
that antihypertensive therapy had an influence on our findings.
An association between diabetes mellitus (DM) and GERD
has been reported previously (20, 21). There are several pos-
sible mechanisms underlying DM-related GERD. In asymp-
tomatic diabetic patients, there is a higher prevalence of abnor-
mal gastroesophageal reflux than among the general popu-
lation (22). The incidence of symptomatic GERD tended to
be higher in diabetic patients with neuropathy than in those
without neuropathy (20). However, the relationship between
glucose intolerance and GERD has not yet been reported. In
the present study, fasting glucose was significantly higher in
subjects with RE than in those without (98.1±16.7 mg/dL
vs. 96.3±18.8 mg/dL, p=0.02), and fasting glucose ≥110
mg/dL was found to be a significant risk factor of RE (OR
1.45, 95% CI 1.13-1.86). Hyperglycemia may influence eso-
phageal motor and sensory function (23). In healthy volun-
teers, hyperglycemia decreases lower esophageal sphincter pres-
sure and the velocity of esophageal peristalsis (24).
Metabolic syndrome has important clinical and public he-
alth implications. In the United States, the unadjusted and
age-adjusted prevalence of metabolic syndrome has been esti-
mated to be 21.8% and 23.7%, respectively (25). In Japan,
the prevalence of metabolic syndrome is 30.6% for men and
3.6% for women (26). In Korea, the prevalence of the metabol-
ic syndrome was reported to be 13.5% for men and 15.0%
for women (27). In the present study, the diagnostic compo-
nents of metabolic syndrome (obesity, high triglyceride, low
HDL cholesterol, high BP and elevated fasting glucose) based
on NCEP criteria (7) were found to be significantly associat-
ed with RE. In metabolic syndrome, insulin resistance is an
important pathogenic factor. Insulin resistance induces sever-
al metabolic changes, including hyperglycemia and dyslipi-
demia (28). Alternative mechanisms might include an asso-
ciation between metabolically active compounds and RE (29).
These and other mechanisms by which obesity may affect risk
for RE, such as growth factors, humoral factors like leptin,
and hormonal factors like estrogen, were not examined in this
study (30). A recent report showed components of the meta-
bolic syndrome such as obesity, hyperglycemia, and hyper-
tension are associated with the occurrence of RE in Japan (31).
However, there was no report about the treatment of metabol-
ic syndrome and improvement of RE until now.
Potential limitations still remain in our study. In this study,
people who attended annual medical check-ups were enrolled
for the assessment of RE. Therefore, the results of this study
were similar, but not identical to those of population-based
studies. We could not evaluate the reflux symptom such as
heartburn, regurgitation, dyspepsia, epigastric pain, belch-
ing, and non-cardiac chest pain because of the retrospective
study. In addition, we did not assess physical data such as
waist-to-hip ratio, so we could not elucidate the prevalence
of metabolic syndrome in our study population. This also
prevented us from making inferences regarding the causali-
ty between metabolic syndrome and RE. However, this is
first study to show the possibility that reflux esophagitis may
be part of the disease spectrum of metabolic syndrome in a
large sample of the Korean population.
In conclusion, the prevalence of RE in healthy subjects who
had a routine check-up was 10.5% in Korea, and nearly ap-
proaches that reported in Western countries. Significant cor-
relations between RE and obesity, high triglyceride, low HDL
cholesterol, high BP, and elevated fasting glucose levels sug-
gested that RE might be part of the disease spectrum of me-
tabolic syndrome. Further studies are needed to evaluate the
relationship between RE and metabolic syndrome.
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